Your personal download of today’s program invitations, prescribing information and more.
Boehringer Ingelheim/Eli Lilly and Company; JARDIANCE JARDIANCE: Data from the Comprehensive Clinical Development Program Saturday, Mar. 16, 2019 |
Novartis Pharmaceuticals Corporation Hospitalization for Heart Failure: A Bad Omen or an Opportunity? Sunday, Mar. 17, 2019 |
Novo Nordisk / Diabetes Booth #1649 Exploring A1C and Cardiovascular Safety Data in T2D Therapies Monday, Mar. 18, 2019 |
Novartis/Entresto Selecting A First-Choice Therapy for Systolic HF Sunday, Mar. 17, 2019 |
ACC.19: Complete Your Educational Experience |
ACC.19: Clinical Focus Sessions |